Paclitaxel Potentiates the Anticancer Effect of Cetuximab by Enhancing Antibody-Dependent Cellular Cytotoxicity on Oral Squamous Cell Carcinoma Cells In Vitro

Administration of cetuximab (C-mab) in combination with paclitaxel (PTX) has been used for patients with head and neck squamous cell carcinoma (SCC) clinically. In this study, we attempted to clarify the molecular mechanisms of the enhancing anticancer effect of C-mab combined with PTX on oral SCC c...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawatani, Yuta, Komiyama, Yuske, Nakashiro, Koh-ichi, Uchida, Daisuke, Fukumoto, Chonji, Shimura, Michiko, Hasegawa, Tomonori, Kamimura, Ryouta, Hitomi-Koide, Masayo, Hyodo, Toshiki, Kawamata, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503545/
https://www.ncbi.nlm.nih.gov/pubmed/32878053
http://dx.doi.org/10.3390/ijms21176292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503545/
https://www.ncbi.nlm.nih.gov/pubmed/32878053
http://dx.doi.org/10.3390/ijms21176292

Ejemplares similares